Potential role for probiotics in the prevention of infectious complications during acute pancreatitis;Potentiële rol voor probiotica bij de preventie van infectieuze complicaties tijdens acute pancreatitis

Nederlands Tijdschrift voor Geneeskunde

Volumn 150, Issue 10, 2006, Pages 535-540

  Van Santvoort, H C ^a   Besselink, M G H ^a   Van Minnen, L P ^a   Timmerman, H M ^a   Akkermans, L M A ^a   Gooszen, H G ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PROBIOTIC AGENT;

ACUTE PANCREATITIS; BACTERIAL OVERGROWTH; BACTERIAL TRANSLOCATION; CLINICAL TRIAL; HUMAN; INFECTIOUS COMPLICATION; INTESTINE MOTILITY; MEDICAL RESEARCH; MORTALITY; NONHUMAN; PANCREAS NECROSIS; PATHOPHYSIOLOGY; REVIEW;

BACTERIAL TRANSLOCATION; HUMANS; INFECTION CONTROL; PANCREATITIS, ACUTE NECROTIZING; PROBIOTICS; RANDOMIZED CONTROLLED TRIALS;

EID: 33644934558     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. Besselink MGH, Bollen TL, Boermeester MA, Ramshorst B van, Leeuwen MS van, Gooszen HG. Timing en keuze van interventie bij necrotiserende pancreatitis. Ned Tijdschr Geneeskd. 2005;149:501-6.
2. Berger P, Mollema R, Girbes ARJ, Dullemen H van, Bosscha K, Gooszen HG, et al. Acute pancreatitis, een voorstel tot een protocol voor diagnostiek en behandeling. Ned Tijdschr Geneeskd. 2001;145: 1970-5.
3. Isenmann R, Runzi M, Kron M, Kahl S, Kraus D, Jung N, et al. Prophylactic antibiotic treatment in patients with predicted severe acute pancreatitis: a placebo-controlled, double-blind trial. Gastroenterology. 2004;126:997-1004.
4. Luiten EJ, Hop WC, Lange JF, Bruining HA. Controlled clinical trial of selective decontamination for the treatment of severe acute pancreatitis. Ann Surg. 1995;222:57-65.
5. Working Party of the British Society of Gastroenterology; Association of Surgeons of Great Britain and Ireland; Pancreatic Society of Great Britain and Ireland; Association of Upper GI Surgeons of Great Britain and Ireland. UK guidelines for the management of acute pancreatitis. Gut. 2005;54 Suppl 3:iii1-9.
6. Manson WL, Dijkstra HM. Bacteriële translocatie, een mechanisme bij het ontstaan van sepsis. Ned Tijdschr Geneeskd. 1994;138: 1603-6.
7. Besselink MGH, Timmerman HM, Minnen LP van, Akkermans LM, Gooszen HG. Prevention of infectious complications in surgical patients: potential role of probiotics. Dig Surg. 2005;22:234-44.
8. Marik PE, Zaloga GP. Meta-analysis of parenteral nutrition versus enterai nutrition in patients with acute pancreatitis. BMJ. 2004;328: 1407.
9. Olah A, Belagyi T, Issekutz A, Gamal ME, Bengmark S. Randomized clinical trial of specific lactobacillus and fibre supplement to early enterai nutrition in patients with acute pancreatitis. Br J Surg. 2002; 89:1103-7.
10. Timmerman HM, Koning CJ, Mulder L, Rombouts FM, Beynen AC. Monostrain, multistrain and multispecies probiotics - a comparison of functionality and efficacy. Int J Food Microbiol. 2004;96: 219-33.
11. Nieuwenhuijs VB, Besselink MGH, Minnen LP van, Gooszen HG. Surgical management of acute necrotizing pancreatitis: a 13-year experience and a systematic review. Scand J Gastroenterol Suppl. 2003;(239):III-6.
12. Bradley 3rd EL. A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, Ga, September 11 through 13, 1992. Arch Surg. 1993;128:586-90.
13. Werner J, Feuerbach S, Uhl W, Buchler MW. Management of acute pancreatitis: from surgery to interventional intensive care. Gut. 2005; 54:426-36.
14. Beger HG, Rau B, Mayer J, Pralle U. Natural course of acute pancreatitis. World J Surg. 1997;21:130-5.
15. Steer ML. Relationship between pancreatitis and lung diseases. Respir Physiol. 2001;128:13-6.
16. McKay CJ, Imrie CW. The continuing challenge of early mortality in acute pancreatitis. Br J Surg. 2004;91:1243-4.
17. Gloor B, Muller CA, Worni M, Martignoni ME, Uhl W, Buchler MW. Late mortality in patients with severe acute pancreatitis. Br J Surg. 2001;88:975-9.
18. Felius ID van, Akkermans LM, Bosscha K, Verheem A, Harmsen W, Visser MR, et al. Interdigestive small bowel motility and duodenal bacterial overgrowth in experimental acute pancreatitis. Neurogastroenterol Motil. 2003;15:267-76.
19. Ridwan BU, Besselink MGH, Koning CJ, Gooszen HG, Akkermans LMA. Prevention of secondary pancreatic infections with probiotics; in vitro studies. Eur J Gastroenterol Hepatol. 2005;17:A42-3.
20. Lutgendorff F, Minnen LP van, Timmerman HM, Gooszen HG, Akkermans LMA. Prophylactic probiotics reduce bacterial translocation in experimental pancreatitis. Eur J Gastroenterol Hepatol. 2006; 18:A2-3.
21. Felius ID van, Kroese ABA, Groot JA, Verheem A, Harmsen W, Visser MR, et al. Increased small intestinal permeability is correlated to experimental acute pancreatitis [proefschrift]. Utrecht: Universiteit Utrecht; 2003. p. 85-99.
22. Ammori BJ, Leeder PC, King RF, Barclay GR, Martin IG, Larvin M, et al. Early increase in intestinal permeability in patients with severe acute pancreatitis: correlation with endotoxemia, organ failure, and mortality. J Gastrointest Surg. 1999;3:252-62.
23. Fioramonti J, Theodorou V, Bueno L. Probiotics: what are they? What are their effects on gut physiology? Best Pract Res Clin Gastroenterol. 2003;17:711-24.
24. Fink MP. Intestinal epithelial hyperpermeability: update on the pathogenesis of gut mucosal barrier dysfunction in critical illness. Curr Opin Crit Care. 2003;9:143-51.
25. Petrof EO, Kojima K, Ropeleski MJ, Musch MW, Tao Y, de Simone C, et al. Probiotics inhibit nuclear factor-kappaB and induce heat shock proteins in colonic epithelial cells through proteasome inhibition. Gastroenterology. 2004;127:1474-87.
26. Rachmilewitz D, Katakura K, Karmeli F, Hayashi T, Reinus C, Rudensky B, et al. Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology. 2004;126:520-8.
27. Niers LE, Timmerman HM, Rijkers GT, Bleek GM van, Uden NO van, Knol EF, et al. Identification of strong interleukin-10 inducing lactic acid bacteria which down-regulate T helper type 2 cytokines. Clin Exp Allergy. 2005;35:1481-9.
28. Rayes N, Seehofer D, Hansen S, Boucsein K, Muller AR, Serke S, et al. Early enteral supply of lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplant recipients. Transplantation. 2O02;74:123-7.
29. Rayes N, Seehofer D, Theruvath T, Schiller RA, Langrehr JM, Jonas S, et al. Supply of pre- and probiotics reduces bacterial infection rates after liver transplantation - a randomized, double-blind trial. Am J Transplant. 2005;5:125-30.
30. Besselink MGH, Timmerman HM, Buskens E, Nieuwenhuijs VB, Akkermans LM, Gooszen HG. Probiotic prophylaxis in patients with predicted severe acute pancreatitis (PROPATRIA): design and rationale of a double-blind, placebo-controlled randomised multicenter trial [ISRCTN38327949]. Dutch Acute Pancreatitis Study Group. BMC Surg. 2004;4:12.
31. Imrie CW, Benjamin IS, Ferguson JC, McKay AJ, Mackenzie I, O'Neill J, et al. A single-centre double-blind trial of Trasylol therapy in primary acute pancreatitis. Br J Surg. 1978;65:337-41.
32. Larvin M, McMahon MJ. APACHE-II score for assessment and monitoring of acute pancreatitis. Lancet. 1989;2(8656):201-5.